Insider Trading Alert - CTSH, CI, ASH, DLR And SYK Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 10, 2013, 123 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $495.90 to $1,382,884,839.00.

Highlighted Stocks Traded by Insiders:

Cognizant Technology Solutions Corporation (CTSH) - FREE Research Report

Schwartz Steven who is EVP, Chief Legal & CAO. at Cognizant Technology Solutions Corporation sold 6,203 shares at $95.06 on Dec. 10, 2013. Following this transaction, the EVP, Chief Legal & CAO. owned 0 shares meaning that the stake was reduced by 100% with the 6,203-share transaction.

McLoughlin Karen who is Chief Financial Officer at Cognizant Technology Solutions Corporation sold 401 shares at $95.06 on Dec. 10, 2013. Following this transaction, the Chief Financial Officer owned 10,137 shares meaning that the stake was reduced by 3.81% with the 401-share transaction.

The shares most recently traded at $94.45, down $0.61, or 0.65% since the insider transaction. Historical insider transactions for Cognizant Technology Solutions Corporation go as follows:

  • 4-Week # shares sold: 24,545
  • 12-Week # shares sold: 42,821
  • 24-Week # shares bought: 7,500
  • 24-Week # shares sold: 146,560

The average volume for Cognizant Technology Solutions Corporation has been 2.0 million shares per day over the past 30 days. Cognizant Technology Solutions Corporation has a market cap of $28.7 billion and is part of the technology sector and computer software & services industry. Shares are up 28.16% year-to-date as of the close of trading on Tuesday.

Cognizant Technology Solutions Corporation provides information technology (IT), consulting, and business process outsourcing services worldwide. The company operates through four segments: Financial Services; Healthcare; Manufacturing, Retail, and Logistics; and Other. The company has a P/E ratio of 24.4. Currently there are 14 analysts that rate Cognizant Technology Solutions Corporation a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CTSH - FREE

TheStreet Quant Ratings rates Cognizant Technology Solutions Corporation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Cognizant Technology Solutions Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cigna (CI) - FREE Research Report

Zollars William D who is Director at Cigna sold 514 shares at $86.44 on Dec. 10, 2013. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 514-share transaction.

The shares most recently traded at $85.15, down $1.29, or 1.52% since the insider transaction. Historical insider transactions for Cigna go as follows:

  • 4-Week # shares sold: 5,514
  • 12-Week # shares sold: 5,667
  • 24-Week # shares sold: 33,243

The average volume for Cigna has been 1.8 million shares per day over the past 30 days. Cigna has a market cap of $24.1 billion and is part of the health care sector and health services industry. Shares are up 63.02% year-to-date as of the close of trading on Tuesday.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. The stock currently has a dividend yield of 0.05%. The company has a P/E ratio of 13.2. Currently there are 9 analysts that rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CI - FREE

TheStreet Quant Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Cigna Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Ashland (ASH) - FREE Research Report

Willis J Kevin who is Chief Financial Officer at Ashland sold 1,012 shares at $95.00 on Dec. 10, 2013. Following this transaction, the Chief Financial Officer owned 1,199 shares meaning that the stake was reduced by 45.77% with the 1,012-share transaction.

The shares most recently traded at $92.52, down $2.48, or 2.68% since the insider transaction. Historical insider transactions for Ashland go as follows:

  • 4-Week # shares sold: 1,336
  • 12-Week # shares sold: 1,820
  • 24-Week # shares sold: 101,789

The average volume for Ashland has been 711,900 shares per day over the past 30 days. Ashland has a market cap of $7.4 billion and is part of the basic materials sector and chemicals industry. Shares are up 16.45% year-to-date as of the close of trading on Tuesday.

Ashland Inc. operates as a specialty chemicals company worldwide. The company operates through four segments: Ashland Specialty Ingredients, Ashland Water Technologies, Ashland Performance Materials, and Ashland Consumer Markets. The stock currently has a dividend yield of 1.43%. The company has a P/E ratio of 11.2. Currently there are 4 analysts that rate Ashland a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ASH - FREE

TheStreet Quant Ratings rates Ashland as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, compelling growth in net income, attractive valuation levels, expanding profit margins and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Ashland Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Digital Realty (DLR) - FREE Research Report

Stein A William who is CFO & Chief Investment Officer at Digital Realty bought 4,000 shares at $45.60 on Dec. 10, 2013. Following this transaction, the CFO & Chief Investment Officer owned 6,017 shares meaning that the stake was reduced by 198.31% with the 4,000-share transaction.

The shares most recently traded at $45.80, up $0.20, or 0.44% since the insider transaction. Historical insider transactions for Digital Realty go as follows:

  • 4-Week # shares bought: 16,009
  • 12-Week # shares bought: 41,209
  • 24-Week # shares bought: 46,209

The average volume for Digital Realty has been 1.8 million shares per day over the past 30 days. Digital Realty has a market cap of $5.9 billion and is part of the financial sector and real estate industry. Shares are down 31.15% year-to-date as of the close of trading on Tuesday.

Digital Realty Trust, Inc., a real estate investment trust (REIT), through its controlling interest in Digital Realty Trust, L.P., engages in the ownership, acquisition, development, redevelopment, and management of technology-related real estate. The stock currently has a dividend yield of 6.84%. The company has a P/E ratio of 21.2. Currently there are 5 analysts that rate Digital Realty a buy, no analysts rate it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DLR - FREE

TheStreet Quant Ratings rates Digital Realty as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including poor profit margins and a generally disappointing performance in the stock itself. Get the full Digital Realty Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Stryker Corporation (SYK) - FREE Research Report

Stryker Ronda E who is Director at Stryker Corporation sold 14,000 shares at $74.48 on Dec. 10, 2013. Following this transaction, the Director owned 11.4 million shares meaning that the stake was reduced by 0.12% with the 14,000-share transaction.

The shares most recently traded at $73.63, down $0.85, or 1.16% since the insider transaction. Historical insider transactions for Stryker Corporation go as follows:

  • 12-Week # shares sold: 2,000
  • 24-Week # shares sold: 2,000

The average volume for Stryker Corporation has been 1.3 million shares per day over the past 30 days. Stryker Corporation has a market cap of $28.2 billion and is part of the health care sector and health services industry. Shares are up 35.72% year-to-date as of the close of trading on Tuesday.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. The stock currently has a dividend yield of 1.64%. The company has a P/E ratio of 32.0. Currently there are 14 analysts that rate Stryker Corporation a buy, 1 analyst rates it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SYK - FREE

TheStreet Quant Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%